Results 201 to 210 of about 195,911 (265)
A Plug‐and‐Play Platform for Customizing Multivalent Degraders and Degrader‐Drug Conjugates
Membrane proteins remain challenging targets for conventional TPD approaches. Here, the authors develop UPTAB, a modular platform leveraging ultrahigh‐affinity orthogonal Im/CL protein pairs for lysosomal degradation of membrane proteins. Mono‐targeted (Type‐I), dual‐targeted (Type‐II), and tri‐targeted (Type‐III) UPTABs enable simultaneous degradation
Mengqing Zhao +7 more
wiley +1 more source
Nanoparticle vaccine formulations for dengue virus.
Murphy CT, Ainslie KM.
europepmc +1 more source
Reply to Claus Juergen Preusse. [PDF]
Settepani F.
europepmc +1 more source
Edible coatings and plasma-activated water: synergistic strategies for extending fresh produce shelf life. [PDF]
Boyapati T, Muthukumarappan K.
europepmc +1 more source
Waning immunity and the future of booster vaccination strategies in global vaccine programs post COVID-19. [PDF]
Biswas R +6 more
europepmc +1 more source
Skin examination in extreme conditions. [PDF]
Igielska-Kalwat J.
europepmc +1 more source
Robust Bioconjugated Antigens Induce Immune Responses Preventing Malaria Infection and its Transmission. [PDF]
Sivakumaran N +10 more
europepmc +1 more source
Auxin treatments protect male reproductive development against cold stress
openaire +2 more sources

